Dominique Vanfleteren at Oxurion (BRU: OXUR)

Oxurionis a developer of ophthalmic medicines designed to deliver next-generation treatments for vitreoretinal disorders, with a focus on diabetic eye disease

Contact

Firm

Oxurion (BRU: OXUR)

Location

Belgium

Investment Stage

Growth

Geographic Focus

BelgiumEurope

About Dominique Vanfleteren

Enriching content...

Similar Investors in Europe

Grégoire Sentilhes at NextStage AM (PAR: NEXTS)

Software, Media • France

Thomas Pozios at Otlet Capital Management

General Investment • Unknown

Anthony Acampora at Altaira Wealth Management SA

Wealth Management • Switzerland

Abhishek Agarwal at Abhishek Agarwal

General Investment • Unknown

Contact Oxurion (BRU: OXUR)

Get in touch for investment criteria and partnership opportunities.

Contact